Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides

Antisense Nucleic Acid Drug Dev. 1999 Apr;9(2):145-54. doi: 10.1089/oli.1.1999.9.145.

Abstract

Inhibition of hepatitis C virus (HCV) gene expression by antisense oligonucleotides was investigated using both a rabbit reticulocyte lysate in vitro translation assay and a transformed human hepatocyte cell expression assay. Screening of overlapping oligonucleotides complementary to the HCV 5' noncoding region and the core open reading frame (ORF) identified a region susceptible to translation inhibition between nucleotides 335 and 379. Comparison of 2'-deoxy-, 2'-O-methyl-, 2'-O-methoxyethyl-, 2'-O-propyl-, and 2'-fluoro-modified phosphodiester oligoribonucleotides demonstrated that increased translation inhibition correlated with both increased binding affinity and nuclease stability. In cell culture assays, 2'-O-methoxyethyl-modified oligonucleotides inhibited HCV core protein synthesis with comparable potency to phosphorothioate oligodeoxynucleotides. Inhibition of HCV core protein expression by 2'-modified oligonucleotides occurred by an RNase H-independent translational arrest mechanism.

MeSH terms

  • 5' Untranslated Regions
  • Animals
  • Hepacivirus / genetics*
  • Humans
  • Liver / cytology
  • Oligodeoxyribonucleotides, Antisense / pharmacology
  • Oligonucleotides, Antisense / pharmacology*
  • Protein Biosynthesis / drug effects*
  • RNA, Viral / genetics
  • Rabbits
  • Thionucleotides / pharmacology
  • Viral Core Proteins / biosynthesis*
  • Viral Core Proteins / genetics

Substances

  • 5' Untranslated Regions
  • Oligodeoxyribonucleotides, Antisense
  • Oligonucleotides, Antisense
  • RNA, Viral
  • Thionucleotides
  • Viral Core Proteins
  • nucleocapsid protein, Hepatitis C virus